Peter Arlett

Nov 22, 2024 | ascpt.onlinelibrary.wiley.com | Peter Arlett |Kit C. Roes |Luis Correia Pinheiro |Flora Musuamba Tshinanu

The European Medicines Regulatory Network (EMRN) has developed a multi-annual workplan to leverage artificial intelligence (AI) for public and animal health. The plan focuses on regulating products including AI in their lifecycle, enhancing process efficiency, and advancing healthcare data analytics through four streams: guidance and policy, tools and technology, collaboration and change management, and experimentation.

Jun 22, 2023 | bpspubs.onlinelibrary.wiley.com | Rosa Gonzalez-Quevedo |Juan Garcia Burgos |Peter Arlett |Laura Pioppo

Academics, clinical researchers, drug developers and other key stakeholders such as patient advocates are being encouraged to take part in a public consultation1 recently launched by the European Medicines Agency (EMA) that will inform re-shaping of the EU transparency rules for clinical trials.

Apr 3, 2023 | bmj.com | Daniel Morales |Peter Arlett |European Medicines Agency

News & ViewsRCTs and real world...

Mar 21, 2023 | bmj.com | Daniel Morales |Peter Arlett

Dear Editor,We read with interest the article by Wieseler et al. This topic is of importance to medicines regulation but the article presents a distorted view of the current work on real-world evidence (RWE).